Literature DB >> 12193581

Calmodulin-dependent kinase I regulates adrenal cell expression of aldosterone synthase.

Jennifer C Condon1, Vincenzo Pezzi, Brad M Drummond, Su Yin, William E Rainey.   

Abstract

Aldosterone synthase (CYP11B2) is expressed in the adrenal glomerulosa and controls the capacity of the adrenal glomerulosa to produce aldosterone. Herein, human NCI-H295R (H295R) adrenocortical cells were used to define the calcium-dependent mechanisms regulating CYP11B2 gene transcription using reporter constructs containing CYP11B2 gene 5'-flanking DNA. Treatment of H295R cells with calcium/calmodulin-dependent protein kinase (CaMK) inhibitor (KN93) or calmodulin inhibitor (calmidazolium) blocked angiotensin II and potassium (K(+)) stimulation of CYP11B2 reporter gene expression. To determine which CaMK regulates CYP11B2, vectors containing the complete coding sequences for CaMKI, CaMKII, and CaMKIV were transfected with the CYP11B2 reporter construct. CaMKI augmented reporter expression when cellular calcium was elevated by ionomycin, whereas CaMKIV had a small effect, and CaMKII had no effect. To further study the role of CaMKs, constitutively active forms of CaMKI (CaMKI-295), II (CaMKII-290), and IV (CaMKIV-313) were transfected with CYP11B2 reporter constructs. CaMKI-295 and, to a lesser degree, CaMKIV-313 were able to stimulated reporter activity. Mutational analysis of the 5'-flanking region of CYP11B2 revealed that a cAMP regulatory element (-71/-64) was necessary for CaMKI induction of reporter gene activity. CaMKI expression was shown in adrenal cortex and H295R cells using immunohistochemistry and Western and Northern analyses. These findings suggest that CaMKI is involved in angiotensin II and K(+) stimulation of CYP11B2 transcription and, therefore, the capacity of the adrenal to produce aldosterone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12193581     DOI: 10.1210/en.2001-211359

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  34 in total

Review 1.  Minireview: aldosterone biosynthesis: electrically gated for our protection.

Authors:  Nick A Guagliardo; Junlan Yao; Changlong Hu; Paula Q Barrett
Journal:  Endocrinology       Date:  2012-06-11       Impact factor: 4.736

2.  Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.

Authors:  Silvia Monticone; Namita G Hattangady; Koshiro Nishimoto; Franco Mantero; Beatrice Rubin; Maria Verena Cicala; Raffaele Pezzani; Richard J Auchus; Hans K Ghayee; Hirotaka Shibata; Isao Kurihara; Tracy A Williams; Judith G Giri; Roni J Bollag; Michael A Edwards; Carlos M Isales; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2012-05-24       Impact factor: 5.958

Review 3.  Acute and chronic regulation of aldosterone production.

Authors:  Namita G Hattangady; Lawrence O Olala; Wendy B Bollag; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2011-08-04       Impact factor: 4.102

4.  Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.

Authors:  Kenji Oki; Maria W Plonczynski; Milay Luis Lam; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

5.  Dihydrotestosterone stimulates aldosterone secretion by H295R human adrenocortical cells.

Authors:  Licy L Yanes; Damian G Romero
Journal:  Mol Cell Endocrinol       Date:  2009-01-21       Impact factor: 4.102

6.  PCP4: a regulator of aldosterone synthesis in human adrenocortical tissues.

Authors:  Saulo J A Felizola; Yasuhiro Nakamura; Yoshikiyo Ono; Kanako Kitamura; Kumi Kikuchi; Yoshiaki Onodera; Kazue Ise; Kei Takase; Akira Sugawara; Namita Hattangady; William E Rainey; Fumitoshi Satoh; Hironobu Sasano
Journal:  J Mol Endocrinol       Date:  2014-02-24       Impact factor: 5.098

Review 7.  Molecular aspects of structure, gating, and physiology of pH-sensitive background K2P and Kir K+-transport channels.

Authors:  Francisco V Sepúlveda; L Pablo Cid; Jacques Teulon; María Isabel Niemeyer
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

Review 8.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

Review 9.  Role of KCNJ5 in familial and sporadic primary aldosteronism.

Authors:  Paolo Mulatero; Silvia Monticone; William E Rainey; Franco Veglio; Tracy Ann Williams
Journal:  Nat Rev Endocrinol       Date:  2012-12-11       Impact factor: 43.330

Review 10.  Aldosterone and cardiovascular disease: the heart of the matter.

Authors:  B Julie He; Mark E Anderson
Journal:  Trends Endocrinol Metab       Date:  2012-10-03       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.